Zacks Investment Research
04 Sept 2026, 22:45 UTC · 5h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
Bristol Myers Squibb (BMY) is projected to report an EPS of $1.68 and revenue of $12.46 billion in its forthcoming earnings report. — Anticipated year-over-year growth in both EPS (3.07%) and revenue (1.93%) is generally positive, though the growth rates are modest.
+0.20Full-year Zacks Consensus Estimates forecast earnings of $6.86 per share and revenue of $49.82 billion, an increase of 11.54% and 3.38% respectively. — Double-digit annual earnings growth provides a positive long-term outlook for the stock's valuation.
+0.20The Zacks Consensus EPS estimate for Bristol Myers Squibb has shifted 0.27% downward over the past month. — Minor downward revisions in earnings estimates typically signal a slight decrease in analyst optimism.
-0.10Continue reading
6 related stories
Top 3 movers · tap to explore
Bristol Myers Squibb currently holds a Zacks Rank of #3 (Hold). — A 'Hold' rating indicates a neutral near-term outlook with no strong catalyst for price movement.
+0.00Which stocks this story touches
The company shows positive projected growth in EPS and revenue for the upcoming quarter and year, despite a slight recent dip in stock price.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
5h ago
